SBC Medical Group Holdings Incorporated (SBCWW)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SBC Medical Group Holdings Incorporated (SBCWW) trades at $0.29 with AI Score 60/100 (Grade B+). SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers across Japan, Vietnam, the United States, and internationally. Market cap: $29.56M, Sector: Industrials.
Price live · AI analysis from May 9, 2026Analyst Coverage for SBCWW: SBCWW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SBCWW against Industrials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SBCWW: 3/4 perspectives are bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →SBC Medical Group Holdings Incorporated (SBCWW) Industrial Operations Profile
SBC Medical Group Holdings Incorporated offers management services to cosmetic treatment centers globally, providing advertising, staff training, clinic design, and medical equipment procurement. With a strong profit margin and a low P/E ratio, the company is positioned within the growing aesthetics and wellness industry.
What Is the Investment Thesis for SBCWW?
SBC Medical Group Holdings Incorporated presents a compelling investment thesis based on its established presence in the growing cosmetic treatment industry and its comprehensive service offerings. With a P/E ratio of 0.5 and a profit margin of 29.4%, the company demonstrates strong profitability relative to its market capitalization of $29.56M. Growth catalysts include the expansion of cosmetic treatment centers in emerging markets and the increasing demand for aesthetic procedures. The company's ability to leverage its established infrastructure and expertise to support franchisee growth is a key value driver. However, potential risks include increased competition in the management services sector and regulatory changes impacting the cosmetic treatment industry. Investors should monitor the company's ability to maintain its profit margins and expand its service offerings to sustain long-term growth.
Based on FMP financials and quantitative analysis
SBCWW Key Highlights
- Market capitalization of $29.56M, reflecting its current valuation in the market.
- P/E ratio of 0.5, indicating a potentially undervalued stock relative to its earnings.
- Profit margin of 29.4%, showcasing strong profitability in the consulting services sector.
- Gross margin of 72.9%, highlighting efficient cost management in service delivery.
- Beta of 0.99, suggesting the stock's volatility is similar to the overall market.
Who Are SBCWW's Competitors?
SBCWW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GLAI Global AI, Inc. | $0.60 | +2.84% | $92.39M | 65 |
| YJGJ Yijia Group Corp. | $4.83 | +0.00% | $40.26M | 64 |
| ROMA Roma Green Finance Limited | $8.58 | +6.58% | $511.06M | 61 |
| NORD Nordicus Partners Corporation | $2.74 | +11.84% | $51.75M | 60 |
| CPBLF ALS Limited | $14.50 | -10.00% | $7.36B | 58 |
| VRSK Verisk Analytics, Inc. | $187.81 | -0.29% | $24.61B | 57 |
| FCN FTI Consulting, Inc. | $154.56 | +0.63% | $4.66B | 56 |
| GRNQ Greenpro Capital Corp. | $1.44 | -3.69% | $11.92M | 56 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SBCWW's Key Strengths?
- Comprehensive suite of management services.
- Established presence in multiple countries.
- Strong relationships with franchisee clinics.
- High profit margin of 29.4%.
What Are SBCWW's Weaknesses?
- Small market capitalization of $29.56M.
- Limited brand recognition compared to larger consulting firms.
- Dependence on the cosmetic treatment industry.
- Potential vulnerability to regulatory changes.
What Could Drive SBCWW Stock Higher?
- Expansion into new geographic markets, particularly in Southeast Asia and Latin America, to capitalize on the growing demand for cosmetic procedures.
- Continued development and enhancement of IT software solutions to improve the operational efficiency of franchisee clinics.
- Strategic partnerships with medical equipment suppliers and marketing agencies to offer a more comprehensive solution to clients.
- Investment in training and education programs for franchisee staff to enhance the quality of service.
What Are the Key Risks for SBCWW?
- Increased competition from larger consulting firms and specialized management service providers.
- Economic downturn impacting consumer spending on cosmetic procedures.
- Regulatory changes affecting the cosmetic treatment industry, such as stricter licensing requirements or advertising restrictions.
- Negative publicity or reputational damage due to adverse events at franchisee clinics.
- Dependence on the cosmetic treatment industry, which is subject to changing consumer preferences and trends.
What Are the Growth Opportunities for SBCWW?
- Expansion into Emerging Markets: The increasing demand for cosmetic procedures in emerging markets such as Southeast Asia and Latin America presents a significant growth opportunity for SBC Medical Group Holdings. By leveraging its existing expertise and infrastructure, the company can establish new partnerships with cosmetic treatment centers in these regions. This expansion can drive revenue growth and diversify the company's geographic footprint. The global cosmetic surgery and procedures market is projected to reach $43.9 billion by 2028, offering a substantial addressable market for SBC Medical Group Holdings.
- Enhancement of IT Software Solutions: Investing in the development and enhancement of its IT software solutions can provide SBC Medical Group Holdings with a competitive advantage. By offering advanced booking, patient management, and data analytics tools, the company can attract new franchisee clients and improve the operational efficiency of existing clients. The global healthcare IT market is expected to reach $390.7 billion by 2024, indicating a strong demand for innovative IT solutions in the healthcare sector.
- Development of New Service Offerings: Expanding its service offerings to include complementary services such as marketing consulting, financial planning, and regulatory compliance can enhance the value proposition for franchisee clients. By providing a comprehensive suite of services, SBC Medical Group Holdings can strengthen its relationships with clients and increase its revenue per client. The global management consulting market is projected to reach $883.53 billion by 2028, highlighting the demand for specialized consulting services.
- Strategic Partnerships and Acquisitions: Pursuing strategic partnerships and acquisitions can enable SBC Medical Group Holdings to expand its market reach and enhance its service capabilities. By partnering with complementary businesses such as medical equipment suppliers or marketing agencies, the company can offer a more comprehensive solution to its clients. The mergers and acquisitions market in the healthcare sector remains active, providing opportunities for SBC Medical Group Holdings to grow through strategic acquisitions.
- Focus on Training and Education Programs: Investing in comprehensive training and education programs for franchisee staff can improve the quality of service provided by cosmetic treatment centers and enhance customer satisfaction. By offering specialized training in areas such as customer service, sales, and technical skills, SBC Medical Group Holdings can differentiate itself from competitors and attract new franchisee clients. The global corporate training market is expected to reach $402.6 billion by 2027, indicating a strong demand for professional development and training programs.
What Opportunities Does SBCWW Have?
- Expansion into emerging markets.
- Development of new service offerings.
- Strategic partnerships and acquisitions.
- Enhancement of IT software solutions.
What Threats Does SBCWW Face?
- Increased competition in the management services sector.
- Economic downturn impacting consumer spending on cosmetic procedures.
- Regulatory changes affecting the cosmetic treatment industry.
- Negative publicity or reputational damage.
What Are SBCWW's Competitive Advantages?
- Established network of cosmetic treatment centers across multiple countries.
- Comprehensive suite of management services tailored to the cosmetic treatment industry.
- Expertise in advertising, marketing, staff management, and clinic design.
- Strong relationships with medical equipment and consumable suppliers.
- Proprietary IT software solutions designed for cosmetic treatment centers.
What Does SBCWW Do?
Founded in 2000 and headquartered in Irvine, California, SBC Medical Group Holdings Incorporated provides comprehensive management services to cosmetic treatment centers across Japan, Vietnam, the United States, and other international markets. The company's services encompass a wide range of operational and strategic support functions, including advertising and marketing, staff recruitment and training, booking reservations, and assistance with franchisee employee housing and facility rentals. SBC Medical Group Holdings also handles the construction and design of franchisee clinics, ensuring a consistent brand experience and operational efficiency. Furthermore, it manages the procurement of medical equipment and consumables, leveraging economies of scale to reduce costs for its franchisees. Beyond operational support, SBC Medical Group Holdings provides IT software solutions tailored to the needs of cosmetic treatment centers. The company supports a diverse array of cosmetic procedures, including breast augmentation, liposuction, rejuvenation treatments, laser skin toning, and various surgical and non-surgical aesthetic enhancements. This holistic approach positions SBC Medical Group Holdings as a key enabler for cosmetic treatment centers seeking to expand their reach and enhance their service offerings.
What Products and Services Does SBCWW Offer?
- Provides advertising and marketing services to cosmetic treatment centers.
- Offers staff management services, including recruitment and training.
- Manages booking reservations for franchisee clinic customers.
- Assists with franchisee employee housing rentals and facility rentals.
- Handles construction and design of franchisee clinics.
- Procures medical equipment and medical consumables.
- Provides IT software solutions tailored to cosmetic treatment centers.
- Supports a diverse array of cosmetic procedures.
How Does SBCWW Make Money?
- Generates revenue by providing management services to cosmetic treatment centers.
- Charges fees for advertising and marketing services.
- Earns revenue from staff management services, including recruitment and training.
- Receives fees for booking reservations and assisting with housing and facility rentals.
- Profits from the construction and design of franchisee clinics and the procurement of medical equipment.
What Industry Does SBCWW Operate In?
SBC Medical Group Holdings operates within the consulting services industry, specifically catering to the cosmetic treatment sector. The global aesthetics market is experiencing steady growth, driven by increasing disposable incomes, an aging population, and a growing emphasis on personal appearance. Key trends include the rising popularity of non-invasive procedures and the expansion of cosmetic services in emerging markets. The competitive landscape includes both specialized management service providers and larger consulting firms that offer broader business solutions. SBC Medical Group Holdings differentiates itself through its focus on the cosmetic treatment industry and its comprehensive suite of services tailored to the specific needs of cosmetic treatment centers.
Who Are SBCWW's Key Customers?
- Cosmetic treatment centers in Japan, Vietnam, and the United States.
- Franchisee clinic customers seeking management and operational support.
- Medical professionals and staff employed by franchisee clinics.
- Patients seeking cosmetic procedures at franchisee clinics.
- Medical equipment and consumable suppliers.
Company Profile
SBC Medical Group Holdings Incorporated operates in the Consulting Services industry within the Industrials sector. It is headquartered in Irvine, US. The company is led by CEO Yoshiyuki Aikawa. SBCWW has traded publicly since 2022.
How SBC Medical Group Holdings Incorporated Is Valued
SBC Medical Group Holdings Incorporated carries a market capitalization of $29.56M, placing it in the micro-cap category. Relative to its peer group, SBCWW's quantitative score of 60/100 is roughly in line with the peer average of 62/100.
ROE 16%Key Financial Metrics
Return on equity for SBC Medical Group Holdings Incorporated stands at 16.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.5%, showing how much profit it generates from its asset base. SBCWW trades at a trailing price-to-earnings ratio of 0.53, below the Industrials sector average of ~30x. A current ratio of 3.82 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 172.9%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
SBC Medical Group Holdings Incorporated's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.60 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project SBC Medical Group Holdings Incorporated revenue of about $181.0M for fiscal 2026, with EPS near $0.46. The estimate reflects 5 contributing analysts.
SBCWW Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Comprehensive suite of management services.
- Established presence in multiple countries.
- Strong relationships with franchisee clinics.
- High profit margin of 29.4%.
Bear Case
- Small market capitalization of $29.56M.
- Limited brand recognition compared to larger consulting firms.
- Dependence on the cosmetic treatment industry.
- Potential vulnerability to regulatory changes.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SBCWW Latest News
-
SBC Medical will participate in several upcoming investor conferences in May and June 2026
Yahoo! Finance: SBCWW News · May 26, 2026
-
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
Yahoo! Finance: SBCWW News · May 22, 2026
-
Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
Yahoo! Finance: SBCWW News · May 20, 2026
-
SBC: Increased Focus on Non-Aesthetic Specialties & Encouraging Results to-date of Multi-Brand Strategy
Yahoo! Finance: SBCWW News · May 19, 2026
SBCWW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SBCWW.
Price Targets
Wall Street price target analysis for SBCWW.
SBCWW MoonshotScore
What does this score mean?
The MoonshotScore rates SBCWW's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Consulting ServicesLatest News
SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
SBC: Increased Focus on Non-Aesthetic Specialties & Encouraging Results to-date of Multi-Brand Strategy
Leadership: Yoshiyuki Aikawa
Unknown
Yoshiyuki Aikawa serves as the CEO of SBC Medical Group Holdings Incorporated, overseeing the company's operations and strategic direction. His leadership is instrumental in managing a workforce of 863 employees across multiple international locations. Information regarding his detailed career history, educational background, and previous roles is not available in the provided data.
Track Record: Due to limited information, specific achievements, strategic decisions, and company milestones under Yoshiyuki Aikawa's leadership cannot be detailed. His role involves guiding the company's expansion and service delivery in the cosmetic treatment sector.
SBCWW Industrials Stock FAQ
What does SBC Medical Group Holdings Incorporated do?
SBC Medical Group Holdings Incorporated provides comprehensive management services to cosmetic treatment centers across Japan, Vietnam, the United States, and internationally. These services include advertising and marketing, staff management, clinic design, medical equipment procurement, and IT software solutions. The company essentially acts as a support system for cosmetic clinics, enabling them to focus on providing cosmetic procedures while SBC handles the operational and administrative aspects of the business.
What do analysts say about SBCWW stock?
Analyst coverage of SBCWW is limited, given its small market capitalization. Key valuation metrics to consider include its low P/E ratio of 0.5 and its high profit margin of 29.4%. Growth considerations revolve around its ability to expand into new markets and enhance its service offerings. Investors should monitor the company's financial performance and its ability to maintain its competitive advantage in the consulting services sector. Further analyst insights are unavailable.
What are the main risks for SBCWW?
The main risks for SBC Medical Group Holdings Incorporated include increased competition in the management services sector, economic downturns impacting consumer spending on cosmetic procedures, and regulatory changes affecting the cosmetic treatment industry. The company's small market capitalization also makes it vulnerable to market volatility. Additionally, negative publicity or reputational damage stemming from adverse events at franchisee clinics could significantly impact the company's brand and financial performance. Dependence on the cosmetic treatment industry is also a risk.
What are the key factors to evaluate for SBCWW?
SBC Medical Group Holdings Incorporated (SBCWW) holds an AI score of 60/100 (moderate). P/E: 0.5x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does SBCWW data refresh on this page?
SBCWW prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SBCWW's recent stock price performance?
SBC Medical Group Holdings Incorporated (SBCWW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of management services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SBCWW overvalued or undervalued right now?
SBC Medical Group Holdings Incorporated (SBCWW) trades at 0.5x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SBCWW?
Before investing in SBC Medical Group Holdings Incorporated (SBCWW), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on provided data and may not reflect the most current developments.
- Limited analyst coverage may affect the accuracy of market sentiment analysis.